CLINICAL DATA MANAGEMENT FEATURED ARTICLES
CLINICAL DATA MANAGEMENT WHITE PAPER & ARTICLES
-
Multi-vendor trial models often limit visibility and coordination. Discover how centralized operations can streamline workflows, control costs, and improve stakeholder experiences.
-
Outdated trial payment processes create costly delays. Explore strategies for centralized financial management, participant reimbursement, and improved study execution.
-
Workflow automation is only part of the solution. Integrating payments, travel, and forecasting with clinical operations supports more efficient trial execution.
-
Outdated payment workflows create delays, financial blind spots, and administrative strain in clinical trials. Evaluating integrated, real-time solutions helps reduce burden, improve visibility, and support more efficient, scalable trial execution.
-
Clinical trials are often slowed by disconnected systems. Centralizing payments, logistics, and data helps streamline operations and retain patients.
CLINICAL DATA MANAGEMENT APPLICATIONS & STUDIES
-
How A Leading Chinese Biopharmaceutical Company Modernized Clinical Operations7/15/2026
A growing biopharma pipeline needed better document oversight. Learn how automation and centralized tracking improved compliance and trial visibility.
-
Maintain Compliance Through Divestiture Without Disrupting Operations6/25/2026
Facing a divestiture? Learn how to protect historical quality records and stay audit-ready throughout the transition.
-
Optimizing Wearable Adherence In A Phase 3 Oncology Trial5/15/2026
Long-term wearable monitoring only works if patients keep wearing the device, and in oncology trials, that’s easier said than done.
-
How A Complex Personalized Medicine Trial Migrated RTSM Software Without Disruption3/26/2026
Discover how a clinical-stage biotech automated its supply chain to protect patient enrollment and eliminate manual errors in a complex, multi-national genetic medicine trial.
-
How A Rare Disease Biotech Replaced Manual Processes With RTSM Software3/26/2026
Discover how a clinical-stage biotech automated its supply chain to protect patient enrollment and eliminate manual errors in a complex, multi-national genetic medicine trial.
SOLUTIONS
- Orchestrated Study Start-Up
- Going The Extra Mile To Enhance Every Patient's Experience
- Suvoda Scheduling
- Medidata CTMS Leads The Industry
- Accelerating Patient Engagement And Recruitment
- LEAP: A Multisensor Wearable For Patient-Centered Clinical Research
- Your Medical Imaging Workflow Solution
- Precision-Built IRT Software That Inspires Quick Action
- Patient-First Solutions For Oncology
- Greenphire Patient Payments
NEWS
-
AEON Biopharma Appoints Industry Veteran Rob Bancroft As Chief Executive Officer4/21/2025
AEON Biopharma, Inc. (“AEON” or the “Company”) (NYSE: AEON), a clinical-stage biopharmaceutical company focused on developing a botulinum toxin complex for the treatment of multiple therapeutic indications, announced today the appointment of Rob Bancroft as President and Chief Executive Officer, effective April 29, 2025. Mr. Bancroft will also join AEON’s Board of Directors.
-
Quantum Biopharma Announces Signing Of An Agreement With A Global Pharmaceutical Contract Research Organization To Prepare An IND (Investigational New Drug) Application Package For Lucid-21-302 (Lucid-MS), A First-In-Class Treatment For Multiple Sclerosis5/20/2025
Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“Quantum BioPharma” or the “Company”), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, today announces that it has signed an agreement with a global pharmaceutical contract research organization to prepare an IND (Investigational New Drug) application package for Lucid-21-302 (Lucid-MS) with the US FDA.
-
Baden-Württemberg's Largest Solar Park Now In Operation5/28/2025
EnBW has commissioned its solar park in Langenenslingen-Wilflingen (district of Biberach in the southwest of Germany).
-
PNE Group Receives Permits For Three New Wind Farms In Germany7/8/2025
In the second quarter of 2025, the PNE Group received the necessary permits for the construction and operation of three onshore wind farms in the German states of Brandenburg, Hesse, and North Rhine-Westphalia.
-
Enhanc3D Genomics Launches Suite Of 3D Multi-Omics Solutions To Accelerate Drug Development1/14/2025
Enhanc3D Genomics (‘Enhanced’ or ‘the Company’), an innovator in 3D genomics technology, today announced the launch of a suite of integrated multi-omics solutions to accelerate and improve the precision of drug discovery.